ArticleTrials2019

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial".

Jan Olof G Karlsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.